Find a research partner or other support function connected to the large scale research facilities, ESS & MAX IV. If you are not ready or not sure what you are looking for start here.
Center Consultation & CRO Laboratory & Lab instruments Large-scale Infrastructure Projects & Networks Research Institute Support organisation University
Clear All
Feedback

Send us your feedback

Here you can send us feedback on the Maxess-website. Please describe the problem or what’s missing in a clear way, and on what page you found the issue. Thank you so much for your help!

    Industry access to world-leading research facilities

    MAXESS is a joint access point for industry to the large-scale research infrastructures MAX IV, ESS, DESY, and the associated networks.

    Discover cases, resources, and our network of experts

    Pharma and Biotechnology

    Finding drug candidates faster

    SARomics Biostructures AB
    Nov 2018 - Nov 2019

    SARomics Biostructures in collaboration with the BioMAX beamline’s scientists successfully tested the feasibility of serial crystallography at MAX IV. The advent of the first fourth-generation synchrotron pioneered by MAX IV finally makes serial crystallography more easily accessible to private companies. Crystals for drug development SARomics Biostructures is a contract research organization (CRO) offering structural biology services in the field of early-stage drug discovery. One of […]

    Energy Applications

    Looking inside a Battery

    Finden Ltd., DESY

    Together with the industry partner FINDEN LTD, DESY scientist used x-ray diffraction computer Tomography to gather insights into the inner life of simple AAA batteries to reveal their aging process and in order to make these last longer.

    Pharma and Biotechnology

    New cancer drugs developed with the help of X-ray crystallography 

    Sprint Bioscience
    Jun 2019 - May 2020

    Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one out of six deaths yearly. Scientists from the drug discovery company Sprint Bioscience and researchers from MAX IV used X-ray crystallography to take important steps toward developing new and more efficient cancer drugs.